To Newsroom

Orifarm and Oriola have signed a long term cooperation agreement

16.8.2018

Pharmaceutical companies Orifarm and Orifarm Generics have signed a cooperation agreement with Oriola, which is a continuation of the 14-year partnership. At Oriola the cooperation is greeted with joy and work is done together with Orifarm by using Oriola’s service portfolio comprehensively.

”Oriola has been a long term trusted partner for us. The challenges last fall were seen also in Orifarm’s business. As both parties  were really committed to the cooperation the problems were solved together. I believe this experience will serve as a solid ground for our future cooperation,” states Sanna Raappana, Managing Director, Orifarm.

Orifarm was founded in Denmark in 1994 by Birgitte and Hans Bøgh-Sørensen. Orifarm operates in nine countries in Europe and in Finland Orifarm is located in Espoo. Orifarm operates in two business areas, in  parallel import of pharmaceuticals and as a supplier of generic pharmaceuticals. The company is the largest supplier of parallel imported pharmaceuticals in Europe and Orifarm Generics is a fast growing supplier of generic pharmaceuticals to the Nordic countries.  The base of Orifarm Group’s business idea is to deliver high-quality medicines at competitive prices and thus provide savings for society and consumers.

”We are truly happy that our cooperation with Orifarm continues and that they trust in our knowhow and will to serve their company’s growth. It is important that we can help our customers to succeed by finding the best solution matching their current needs”, comments Annastiina Palmroth-Holst, Oriola Business Unit Director.

More information:

Tuula Lehto, Group Communications Director, Oriola, + 358 40 588 5343, tuula.lehto@oriola.com

Sanna Raappana, Managing Director, Orifarm Oy / Orifarm Generics Oy, +358 (0)50 518 1173, sra@orifarm.com